Free Trial
NASDAQ:ESRX

Express Scripts (ESRX) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$92.11
$95.87
50-Day Range
$92.33
$92.33
52-Week Range
$66.93
$101.73
Volume
31.61 million shs
Average Volume
6.64 million shs
Market Capitalization
$52.06 billion
P/E Ratio
13.00
Dividend Yield
N/A
Price Target
N/A
ESRX stock logo

About Express Scripts Stock (NASDAQ:ESRX)

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services. This segment also provides Medicare, Medicaid, and health insurance marketplace products; Express Scripts SafeGuardRx, a suite of solutions targeting the therapy classes that pose clinical challenges and budgetary threat to its clients; and Inside Rx, a program that provide affordable access to medication for uninsured and underinsured individuals. Its Other Business Operations segment distributes specialty pharmaceuticals and medical supplies, including injectable and infusible pharmaceuticals and medications to treat specialty and rare/orphan diseases. This segment also provides medical benefit management solutions for radiology, cardiology, musculoskeletal disorders, sleep disorders, post-acute care, genetic lab, specialty pharmacy, and medical oncology. The company serves managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation plans, government health programs, providers, clinics, hospitals, and others. As of December 31, 2017, it operated 4 automated dispensing home delivery pharmacies; 1 non-automated dispensing home delivery pharmacy; 7 non-dispensing order processing centers; 5 patient contact centers; 9 specialty home delivery pharmacies; and 34 specialty branch pharmacies. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in Saint Louis, Missouri.

ESRX Stock News Headlines

Scripts of success
Amazon Pharmacy Fights For Recognition
The Future Of Drugstore Retailing
Express Scripts Stages a Small Comeback
Express Scripts Inc
Express Scripts, Inc.
Express Coupons September 2022
See More Headlines
Receive ESRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Express Scripts and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/31/2018
Today
6/11/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Stores & Proprietary Stores
Sub-Industry
Health Care Services
Current Symbol
NASDAQ:ESRX
CUSIP
30219G10
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$4.52 billion
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$100.06 billion
Cash Flow
$10.49 per share
Book Value
$32.00 per share

Miscellaneous

Free Float
N/A
Market Cap
$52.06 billion
Optionable
Optionable
Beta
0.88
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Should I Buy Express Scripts Stock? ESRX Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Express Scripts Holding:

  • Express Scripts Holding has shown consistent revenue growth over the past few quarters, indicating a strong financial performance.
  • The company has a low debt-to-equity ratio of 1.99, which signifies a healthy balance sheet and financial stability.
  • Express Scripts Holding's market capitalization of $138.88 billion reflects its significant size and market presence, providing stability to investors.
  • The company's P/E ratio of 21.74 suggests that the stock may be undervalued compared to its earnings potential, making it an attractive investment opportunity.
  • With a beta of 1.05, Express Scripts Holding's stock price is relatively stable compared to the overall market, reducing investment risk for shareholders.

Cons

Investors should be bearish about investing in Express Scripts Holding for these reasons:

  • The company's quick ratio of 0.76 and current ratio of 0.93 indicate potential liquidity challenges, which could impact its ability to meet short-term obligations.
  • Express Scripts Holding's fifty-day moving average of $238.36 is below its 200-day moving average of $240.56, suggesting a possible downward trend in the stock price.
  • Analysts have issued mixed ratings on the stock, with some recommending a hold or neutral stance, indicating uncertainty about the company's future performance.
  • The recent dividend announcement of $1.30 per share represents a payout ratio of 49.62%, which may limit future growth opportunities for the company.
  • Express Scripts Holding's price-to-earnings-growth ratio of 1.89 may indicate that the stock is currently overvalued relative to its earnings growth potential, posing a risk for investors.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, June 5, 2024. Please send any questions or comments about these Express Scripts pros and cons to contact@marketbeat.com.

ESRX Stock Analysis - Frequently Asked Questions

How were Express Scripts' earnings last quarter?

Express Scripts Holding (NASDAQ:ESRX) posted its earnings results on Wednesday, October, 31st. The company reported $2.43 EPS for the quarter, beating analysts' consensus estimates of $2.42 by $0.01. The firm earned $25.56 billion during the quarter, compared to the consensus estimate of $25.11 billion. Express Scripts had a trailing twelve-month return on equity of 25.43% and a net margin of 4.83%. The company's quarterly revenue was up 3.6% compared to the same quarter last year. During the same period in the prior year, the company earned $2.51 EPS.

What other stocks do shareholders of Express Scripts own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Express Scripts investors own include Gilead Sciences (GILD), Bank of America (BAC), Cisco Systems (CSCO), General Electric (GE), Intel (INTC), Walt Disney (DIS), CVS Health (CVS), Boeing (BA), Starbucks (SBUX) and Johnson & Johnson (JNJ).

This page (NASDAQ:ESRX) was last updated on 6/11/2024 by MarketBeat.com Staff

From Our Partners